 BUFFALO, N.Y., July 22, 2021 GLOBE NEWSWIRE -- Athenex, Inc. Nasdaq: ATNX, a global biopharmaceutical company dedicated to the discovery, development, and commercialization of novel therapies for the treatment of cancer and related conditions, today announced that the Company will provide a corporate and financial update for the second quarter 2021, on Thursday, August 5, 2021, before the market opens. Athenexs management team will host a conference call and live audio webcast at 8:00am Eastern Time. 